AptaBio Therapeutics Inc
KOSDAQ:293780
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
AptaBio Therapeutics Inc
KOSDAQ:293780
|
KR |
|
E
|
E for L Aim PCL
SET:EFORL
|
TH |
|
L
|
LPS Brasil Consultoria de Imoveis SA
BOVESPA:LPSB3
|
BR |
|
B
|
Bannari Amman Spinning Mills Ltd
NSE:BASML
|
IN |
|
Daifuku Co Ltd
TSE:6383
|
JP |
|
Xinxiang Chemical Fiber Co Ltd
SZSE:000949
|
CN |
|
D
|
Dongwu Cement International Ltd
HKEX:695
|
CN |
|
C
|
Coraza Integrated Technology Bhd
KLSE:CORAZA
|
MY |
|
Shenzhen Aisidi Co Ltd
SZSE:002416
|
CN |
|
Zuming Bean Products Co Ltd
SZSE:003030
|
CN |
|
Hyakujushi Bank Ltd
TSE:8386
|
JP |
|
S
|
StableX Technologies Inc
NASDAQ:SBLX
|
US |
|
S
|
Sterling Bancorp
F:PVDA
|
US |
|
N
|
Newonder Special Electric Co Ltd
SZSE:301120
|
CN |
|
Pansoft Co Ltd
SZSE:300996
|
CN |
AptaBio Therapeutics Inc
Aptabio Therapeutics, Inc. operates as a pharmaceutical biotechnology company that develops intractable innovative drugs based on original platform technology. The company is headquartered in Yongin, Gyeonggi-Do and currently employs 28 full-time employees. The company went IPO on 2019-06-12. The firm is developing anti-cancer drugs, drugs for inflammatory and fibrotic diseases and diabetic complications drugs, among others.
Aptabio Therapeutics, Inc. operates as a pharmaceutical biotechnology company that develops intractable innovative drugs based on original platform technology. The company is headquartered in Yongin, Gyeonggi-Do and currently employs 28 full-time employees. The company went IPO on 2019-06-12. The firm is developing anti-cancer drugs, drugs for inflammatory and fibrotic diseases and diabetic complications drugs, among others.